A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Expression of EMMPRIN as a biomarker in nonodontogenic carcinomas: a histological study
Tekijät: Antisar, Ben Amer M.; Enas, Omar M.; Sahar, Elsheikh M.; Ahmed, Musrati S.
Kustantaja: Taylor & Francis
Julkaisuvuosi: 2026
Lehti: Libyan Journal of Medicine
Artikkelin numero: 2598896
Vuosikerta: 21
Numero: 1
ISSN: 1993-2820
eISSN: 1819-6357
DOI: https://doi.org/10.1080/19932820.2025.2598896
Julkaisun avoimuus kirjaamishetkellä: Avoimesti saatavilla
Julkaisukanavan avoimuus : Kokonaan avoin julkaisukanava
Verkko-osoite: https://doi.org/10.1080/19932820.2025.2598896
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/506317532
EMMPRIN is a widely distributed cell surface glycoprotein that belongs to the immunoglobulin (Ig) superfamily. It induces the production of extracellular matrix metalloproteinases (MMPs) and plays an important role in angiogenesis via stimulation of vascular endothelial growth factor (VEGF). The aim of the present work was to assess and compare the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in different oral nonodontogenic carcinomas. Fifty-four diagnosed cases of oral nonodontogenic carcinomas were selected, and biopsies were taken from the tumor tissue, fixed, processed, and cut into sections to be stained with hematoxylin and eosin (H&E) for routine histopathological examination. Immunohistochemistry was performed for EMMPRIN. All cases showed positive EMMPRIN expression with different intensities. The results were recorded and statistically analyzed using student t-test, Pearson correlation, test and ANOVA test. This study concluded that elevated EMMPRIN expression is correlated with tumor proliferation, angiogenesis, metastasis, and invasion.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
There were no funding agencies involved in our work.